Join our WhatsApp Stock Market News Group at GetPaidIndia on WhatsApp.

This website is purely ACADEMIC in nature and NOT a stock market recommendation service or a tip provider. No live data or feeds are provided and all information is historic only. Information is provided for ease of understanding for the purpose of learning. Accuracy of definitions etc is not mantained. I am not a SEBI or IRDA registered.

Glenmark Pharmaceuticals Limited



From GetPaidIndia.com
Jump to:navigation, search

In The News

GBR 830 is an Investigational, First-in-Class, Anti-OX40 Monoclonal Antibody

Market Capitalization

  • September 1, 2017: Rs. 17216 Cr (Mid Cap)
  • August 24, 2017: Rs. 17393 Cr (Mid Cap)
  • August 22, 2017: Rs. 17048 Cr (Mid Cap)
  • August 7, 2017: Rs. 19398 Cr (Mid Cap)
  • July 31, 2017: Rs. 19371 Cr (Mid Cap)
  • July 21, 2017: Rs. 19650 Cr (Mid Cap)

Related Lesson: Why is Market Capitalization and stock liquidity important for the investor?

Markets Mojo

Date Quality Valuation Financial Trend
September 1, 2017 Excellent (Rank # 3 of 164 ) Very Attractive Positive (Score: 9 )
August 24, 2017 Excellent (Rank # 3 of 164 ) Very Attractive Positive (Score: 9 )
August 22, 2017 Excellent (Rank # 3 of 163 ) Very Attractive Positive (Score: 9 )
August 7, 2017 Excellent (Rank # 3 of 164 ) Very Attractive Positive (Score: 8 )
July 31, 2017 Excellent (Rank # 3 of 164 ) Very Attractive Flat (Score: 8 )
July 21, 2017 Excellent (Rank # 3 of 164 ) Very Attractive Flat (Score: 1 )

Related Lessons: Learn what are Qualitative and Quantitative factors, CMP and Stock valuation and Financial Trend Analysis

MarketSmithIndia Score

Date Master Score EPS Strength Price Strength Buyer Demand Group Rank
August 24, 2017 C Fair: 72 Poor: 16 Fair: C- Poor: 142
August 11, 2017 C Fair: 70 Poor: 12 Poor: D Poor: 138
August 4, 2017 C Fair: 70 Poor: 14 Poor: D+ Poor: 137

Companies with MarketSmithIndia Score of A or B are usually good.

Stock Axis Rating and Ranking

Date Rating Ranking
August 24, 2017 2 / 5 34 / 99

Technical Indicators

Date Present Super Trend Trend Reversal PSAR Williams %R (14) CCI (20) ADX (14)
September 13, 2017 Bearish 590.49 Bullish -65.52 (Neutral) -92 (Neutral) 36.93 (Neutral)
September 1, 2017 Sell 671.69 Sell -62.53 (Neutral) -48 (Neutral) 35.11 (Neutral)
August 24, 2017 Sell 676.53 Sell -82.25 (Oversold) -72 Strong Downtrend (Sell) 39.72 Strong Trend (Buy)
May 24, 2017 Sell 797.21 Sell -95.78 (Oversold) -123 Strong Downtrend (Sell) 41.12 Strong Trend (Buy)
May 19, 2017 Bearish 868.16 Bearish -95.30 Oversold (Bullish) -198 Strong Downtrend (Bearish) 32.75 (Neutral)
May 15, 2017 Bearish 918.55 Bearish -84.88 Oversold (Bullish) -307 Strong Downtrend (Bearish) 25.68 (Neutral)

Chart Frequency: Daily

Supertrend Parameters: Period: 7; Multiplier: 3

Parabolic SAR: Minimum AF: 0.02; Maximum AF: 0.2

Coverage / Ratings / Rankings

Date Source Category Ranking / Description
July 24 - 30, 2017 Money Times Tower Talk If reports are true, Glenmark Pharmaceuticals is expected to get a milestone payment for one of its mole. A good buy at the current beaten down share price.

Financial Results

Historical Data

Related / Peer Companies

Related Categories

External Links